The current study by Xinget al1builds on the work of other investigators that have implicated the CXCR4/SDF1 pathway in promoting prostate cancer cell invasion and metastasis

The current study by Xinget al1builds on the work of other investigators that have implicated the CXCR4/SDF1 pathway in promoting prostate cancer cell invasion and metastasis. arriving in a bone sinusoid. Osteoblasts or bone lining cells express abundant SDF-1 that can interact with tumor cells and/or stem cells. SDF-1 (blue background) creates a chemotactic gradient which directs the migration of cells expressing SDF-1 receptors (CXCR4 or CXCR7) when they enter the sinusoid. (A) Tumor cells responding to SDF-1 can (B) undergo alterations in adhesion molecule (e.g., integrin) expression or activity which, in turn, result in greater adhesion and retention Naltrexone HCl of the tumor cells at the bone, and change expression of growth (C) or survival (D) factors that facilitate tumor growth or confer resistance to the harsh environments encountered in select tissues; and/or (E) undergo induction of secretion of pro-angiogenic signals that recruit endothelial cells and/or bone marrow-derived stem cells. The chemokine receptor CXCR4 is usually one member of a large family ( 18) of G-protein coupled receptors and recognizes peptides (i.e., chemokines) as ligands2,3. SDF1 (also known as CXCL12) is the predominant ligand for CXCR44. The effects of the SDF1/CXCR4 signaling pathway on prostate malignancy are considered to be multifactorial, and it has been implicated in the homing of tumor cells to specific organs (metastasis), as well as the establishment and growth of tumor cells at specific sites, which are most likely mediated by the effects of CXCR4 on malignancy cell adhesion, invasion, and proliferation. The current study by Xinget al1builds on the work of other investigators that have implicated the CXCR4/SDF1 pathway in promoting prostate malignancy cell invasion and metastasis. Examination of CXCR4 expression in individual tumors has shown that it is frequently expressed on metastatic malignancy cells5. A number of organs express SDF1, including the lung, bone, and lymph nodes. Other investigators have used blocking of Naltrexone HCl CXCR4 function with a neutralizing antibody to show that CXCR4 is usually involved in prostate malignancy cell adhesion and invasionin vitro, and the localization of prostate malignancy cells to bone when injected into the heartin vivo. Blocking of CXCR4 function with a neutralizing antibody also had been shown to inhibit tumor growth when prostate malignancy cells were injected directly into the tibial bone69. The Xinget alarticle both confirms and extends these findings by showing that this stable down-regulation of CXCR4 inhibits SDF1-promoted prostate malignancy Naltrexone HCl cell adhesion to osteosarcoma and endothelial cells, inhibits invasion Naltrexone HCl through Matrigel, and reduces the incidence of prostate malignancy establishment and growth when the tumor cells are injected into the tibial bone of mice. Thus, these studies represent an important advance in our knowledge of the role of CXCR4/SDF1 signaling in prostate malignancy metastasis. They also raise several important new questions regarding CXCR4/SDF1 signaling and most especially the effects of this process in the context of other signaling events. SDF1 can bind CXCR7, as well as CXCR4, and it has been reported very recently that this CXCR7/SD1 signaling pathway plays a role in prostate malignancy biology10. It is not obvious whether CXCR7 is usually expressed around the PC3 prostate malignancy cells utilized by Xinget al.1. It is possible, however, that this expression of CXCR7 on these cells accounts for the absence of total inhibition of tumor establishment and growth in the tibia and the absence of total inhibition of cell adhesion and invasionin vitrothat these investigators found utilizing PC3 cells with down-regulated CXCR4. Thus, it would be of interest to determine the relative effect of SDF1 signaling through CXCR4 as compared to CXCR7 on prostate malignancy cell adhesion, invasion and metastasis perhaps through down-regulation of these individual receptors in a cell collection that is known to express both CXCR4 and CXCR7. It would also be interesting to assess whether cells in which CXCR4 is usually down-regulated compensate for this loss by upregulating CXCR7 or other receptors. The obtaining of Xinget al.,1that Naltrexone HCl SDF1 stimulation increases prostate malignancy cell invasion through Matrigel and that this is inhibited with the down-regulation of CXCR4, suggests one possible mechanism Rabbit polyclonal to AGER whereby the SDF1/CXCR4 signaling pathway could promote metastasis. The effects of SDF1 on cell adhesion have been attributed for the most part to changes in the integrin family of cell adhesion receptors. The integrin family of receptors largely recognizes extracellular matrix proteins as ligands and initiates reorganization of the actin cytoskeleton that can lead to cell movement. Specifically, either.